Abstract
The effect of interleukin 4 (IL‐4) on expression of antitumor activity of blood monocytes purified by counter‐flow centrifugal elutriation from healthy donors was examined. The blood monocytes were incubated for 24 h in medium with lipopolysaccharide, interferon γ (IFN‐γ) or desmethyl muramyl dipeptide (norMDP) or with IFN‐γ and norMDP in the presence of IL‐4, and then their tumoricidal activity was assayed by measuring 125IUdR release from human melanoma (A375) cells. Irrespective of activation stimulus, addition of IL‐4 to cultures of monocytes and activators resulted in dose‐dependent suppression of the tumoricidal activity of monocytes against parent A375 melanoma cells and the variant cells, A375‐R resistant to IL‐1 and tumor necrosis factor α. IL‐4 suppressed the early induction phase of monocyte activation. Rabbit anti‐IL‐4 antisera completely blocked the IL‐4‐mediated suppression of monocyte activation to the tumoricidal state. These findings suggest that IL‐4 is important in vivo in down‐regulation of anti‐tumor expression of monocytes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
